Sen. Bernie Sanders speaks on his Medicare for All bill. (Photo: Mark Wilson/Getty Images)

Sen. Bernie Sanders' Medicare for All plan would drastically change not only how health care is paid for, but who ultimately pays for it.

Between the lines: While the wealthy and the poor usually pay the same premium for today's employer-based insurance, Sanders' plan would beef up insurance coverage for everyone and pay for it by increasing taxes disproportionately on the wealthy.

Driving the news: As part of yesterday's rollout, Sanders released a white paper with several "options" on how to raise the additional revenue it would take for the government to pay for everyone's health care without any premiums or out-of-pocket costs.

  • While most people's taxes would go up, the wealthy would end up paying for a much greater portion of the nation's health care system than they currently do.
  • A 4% "income-based premium" for workers who make more than $29,000 and a 7.5% "income-based premium" on employers (exempting the first $2 million in payroll) are two of the financing options. Most economists assume that the employer tax would get passed onto employees through lost wages.
  • Other options include increasing the individual tax rate on high earners, taxing "unearned" income at the same rate as earned, and establishing a wealth tax.

What they're saying: Even if all of these payment options were implemented, they still wouldn't cover the total cost of Sanders' plan, said the Committee for a Responsible Federal Budget's Marc Goldwein.

  • There could also be unintended consequences of such high taxes on the wealthy, he said: “For some people, it would literally cost them money to make investments.”

The bottom line: "More progressive tax-based financing of health care is a feature, not a bug, of Medicare-for-all," the Kaiser Family Foundation's Larry Levitt said.

  • "The idea of financing health care through taxes rather than premiums and out-of-pocket costs would be fairer in some people’s minds, but also disruptive," he said.

Go deeper

Updated 45 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 6 p.m. ET: 13,203,571 — Total deaths: 575,201 — Total recoveries — 7,331,068Map.
  2. U.S.: Total confirmed cases as of 6 p.m. ET: 3,407,798 — Total deaths: 136,252 — Total recoveries: 1,031,939 — Total tested: 41,004,275Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

1 hour ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."